EP1248589A2 - Skin care compositions - Google Patents
Skin care compositionsInfo
- Publication number
- EP1248589A2 EP1248589A2 EP01904937A EP01904937A EP1248589A2 EP 1248589 A2 EP1248589 A2 EP 1248589A2 EP 01904937 A EP01904937 A EP 01904937A EP 01904937 A EP01904937 A EP 01904937A EP 1248589 A2 EP1248589 A2 EP 1248589A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- skin
- compositions
- acid
- preferred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/436—Interference pigments, e.g. Iridescent, Pearlescent
Definitions
- the present invention relates to the field of topical compositions for improving the appearance and feel of human skin. More particularly, the invention relates to topical compositions which provide good coverage of skin imperfections, e.g., pores and uneven skin tone, while retaining a natural skin appearance.
- the compositions of the invention are especially useful for the cosmetic treatment of non-facial parts of the body, especially the hands.
- Topical cosmetic compositions such as skin creams and lotions and the like, can be designed to deliver a variety of post-application benefits to the skin, such as moisturisation, skin protection and improvements to skin feel and appearance.
- benefits may be entirely cosmetic or may be delivered by the use of chronically acting actives which are capable of regulating skin condition, including regulating fine lines, wrinkles and other forms of uneven or rough surface texture associated with aged or photodamaged skin.
- skin products will not only deliver benefits on a longer time scale but will also effect immediately noticeable improvements such as enhanced skin smoothness.
- products have excellent in- use aesthetics i.e. that they can readily be rubbed in without feeling greasy or sticky.
- the present invention also relates to cosmetic methods of improving skin feel and appearance, in particular for providing a more even skin tone, by topical application of the subject compositions.
- compositions are useful for imparting an essentially immediate visual improvement in skin appearance and feel while maintaining a natural skin appearance.
- optically neutral means that when a material is applied to the skin by itself it effects no net colour change other than a possible lightening or darkening of tone.
- ⁇ a and ⁇ b colour shift values defined herein in the section headed 'Green Pigments' will each have a magnitude no greater than one unit, more preferably no greater than one half of one unit, for an optically neutral material.
- Such materials will normally be colourless, white or off-white in bulk appearance.
- compositions useful in the subject invention may be made into a variety of product forms such as are known in the art.
- Preferred compositions have a sufficient thickness or yield point to resist sedimentation of the particulates.
- the diluent is preferably liquid. Water is an especially preferred diluent.
- the composition preferably comprises at least about 60%> of the hydrophilic diluent.
- the emulsion may be or comprise (e.g., in a triple or other multi-phase emulsion) an oil-in-water emulsion or a water-in-oil emulsion such as a water-in-silicone emulsion.
- Preferred subclasses include kaolonite, montmorillonite, talc and mica. Most preferred are talc and mica, especially mica.
- the layer structure of the phyllosilicates gives a smooth feeling upon application to the skin.
- the most preferred materials from the point of view of appearance and skin feel are optically neutral titanium coated micas. These optically neutral titanium coated micas are commercially available and suitable materials include Microna Matte White, available from Rona, a subsidiary of Merck.
- Optional components include emollients, oil absorbents, antimicrobial agents, binders, buffering agents, denaturants, cosmetic astringents, external analgesics, film formers, humectants, opacifying agents, perfumes, pigments, skin soothing and healing agents, preservatives, propellants, skin penetration enhancers, solvents, suspending agents, emulsifiers, cleansing agents, thickening agents, solubilising agents, waxes, sunscreens, sunless tanning agents, antioxidants and/or radical scavengers, chelating agents, anti-acne agents, anti-inflammatory agents, desquamation agents/exfoliants, organic hydroxy acids, vitamins and natural extracts.
- Suitable nylon particles are commercially available from Elf Atochem SA, Paris, France under the tradename Orgasol®.
- the compositions may contain other inorganic or organic particulate materials. However, it is preferred that the organic particulates in the compositions of the invention consist essentially of the particulate material described in this section entitled "Organic Particulate Material.”
- the vitamin B3 compound may be included as the substantially pure material, or as an extract obtained by suitable physical or chemical isolation from natural (e.g., plant) sources.
- the vitamin B3 compound is preferably substantially pure i.e. substantially free of impurities arising from the original source.
- Substantially pure compounds can be provided in solution, optionally with an anti-oxidant or other stabiliser.
- Suitable organopolysiloxanes can be selected from a wide variety of silicones spanning a broad range of volatilities and viscosities. Non-volatile polysiloxanes are preferred. Suitable silicones are disclosed in U.S. Patent No. 5,069,897, issued December 3, 1991. Preferred for use herein are organopolysiloxanes selected from the group consisting of polyalkylsiloxanes, alkyl substituted dimethicones, dimethiconols, poly- alkylaryl siloxanes, and mixtures thereof. More preferred for use herein are polyalkylsiloxanes and cyclomethicones. Preferred among the polyalkylsiloxanes are dimethicones.
- C4-C20 alkyl ethers of polypropylene glycols C1-C20 carboxylic acid esters of polypropylene glycols, and di-Cg-C3o alkyl ethers, examples of which include PPG- 14 butyl ether, PPG- 15 stearyl ether, dioctyl ether, dodecyl octyl ether, and mixtures thereof.
- nonionic surfactants are the condensation products of alkylene oxides with both fatty acids and fatty alcohols [i.e. wherein the polyalkylene oxide portion is esterified on one end with a fatty acid and etherified (i.e. connected via an ether linkage) on the other end with a fatty alcohol].
- RCO(X) n OR' wherein R and R' are CIQ-30 alkyl groups, X is -OCH2CH2 (i.e.
- compositions of the present invention can also comprise a skin lightening agent.
- the compositions preferably comprise from about 0.1%> to about 10%>, more preferably from about 0.2% to about 5%, also preferably from about 0.5% to about 2%, of a skin lightening agent.
- Suitable skin lightening agents include those known in the art, including kojic acid, arbutin, ascorbic acid and derivatives thereof, e.g., magnesium ascorbyl phosphate.
- Further skin lightening agents suitable for use herein also include those described in WO 95/34280 and WO 95/23780.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0001235A GB0001235D0 (en) | 2000-01-19 | 2000-01-19 | Skin care compositions |
GB0001235 | 2000-01-19 | ||
GB0001311 | 2000-01-20 | ||
GB0001311A GB0001311D0 (en) | 2000-01-20 | 2000-01-20 | Cosmetic compositions |
PCT/US2001/001827 WO2001052795A2 (en) | 2000-01-19 | 2001-01-18 | Skin care compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1248589A2 true EP1248589A2 (en) | 2002-10-16 |
Family
ID=26243432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01904937A Withdrawn EP1248589A2 (en) | 2000-01-19 | 2001-01-18 | Skin care compositions |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1248589A2 (ja) |
JP (1) | JP2003520217A (ja) |
CN (1) | CN1396817A (ja) |
AU (1) | AU2001232866A1 (ja) |
MX (1) | MXPA02007045A (ja) |
WO (1) | WO2001052795A2 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10311302A1 (de) * | 2003-03-14 | 2004-09-23 | Beiersdorf Ag | Dekorative Kosmetikprodukte mit Effektpigmenten |
FR2856594B1 (fr) * | 2003-06-26 | 2006-03-03 | Oreal | Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s) |
DE10357046A1 (de) † | 2003-12-04 | 2005-06-30 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen enthaltend eine Kombination aus grünem Farbstoff und antiinflammatorischem Wirkstoff |
DE102004012135A1 (de) * | 2004-03-12 | 2005-09-29 | Beiersdorf Ag | Zubereitung gegen gerötete Haut |
CN100352423C (zh) * | 2005-11-15 | 2007-12-05 | 湖南师范大学 | 一种含龟皮胶原的护肤品及其制备 |
JP4968722B2 (ja) * | 2006-09-22 | 2012-07-04 | 株式会社 資生堂 | 水中油型乳化皮膚化粧料 |
JP2010515720A (ja) * | 2007-01-16 | 2010-05-13 | ザ プロクター アンド ギャンブル カンパニー | 化粧品組成物 |
US9993397B2 (en) | 2010-11-23 | 2018-06-12 | Conopco Inc. | Composite particles and compositions with composite particles |
ES2749602T3 (es) * | 2014-07-30 | 2020-03-23 | Icb Pharma Spolka Jawna | Composición de dispersión líquida libre de siloxano que comprende isopropilmiristato e isohexadecano para combatir ectoparásitos |
US20180369137A1 (en) * | 2017-06-27 | 2018-12-27 | Lifestyles Healthcare Pte. Ltd. | Natural Lubricant |
WO2020075792A1 (ja) * | 2018-10-10 | 2020-04-16 | 株式会社 資生堂 | 凹凸補正用外用剤 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20013177A3 (cs) * | 1999-03-03 | 2002-03-13 | The Procter & Gamble Company | Kompozice pro péči o ple» |
-
2001
- 2001-01-18 WO PCT/US2001/001827 patent/WO2001052795A2/en not_active Application Discontinuation
- 2001-01-18 MX MXPA02007045A patent/MXPA02007045A/es unknown
- 2001-01-18 EP EP01904937A patent/EP1248589A2/en not_active Withdrawn
- 2001-01-18 AU AU2001232866A patent/AU2001232866A1/en not_active Abandoned
- 2001-01-18 JP JP2001552844A patent/JP2003520217A/ja active Pending
- 2001-01-18 CN CN 01803849 patent/CN1396817A/zh active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO0152795A3 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA02007045A (es) | 2002-12-13 |
JP2003520217A (ja) | 2003-07-02 |
CN1396817A (zh) | 2003-02-12 |
WO2001052795A2 (en) | 2001-07-26 |
WO2001052795A3 (en) | 2002-01-10 |
AU2001232866A1 (en) | 2001-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU771193B2 (en) | Niacinamide compositions with reduced tack | |
EP1156772B1 (en) | Skin care compositions | |
US6551604B1 (en) | Skin care compositions | |
AU752147B2 (en) | Skin care compositions | |
JP3786212B2 (ja) | スキンケア組成物および皮膚外観の改良方法 | |
CZ295344B6 (cs) | Zevně působící směs pro péči o pokožku | |
KR20010031994A (ko) | 피부 보호 조성물 및 피부외관 향상 방법 | |
US20030211058A1 (en) | Skin care compositions | |
WO2001052795A2 (en) | Skin care compositions | |
US20010009671A1 (en) | Cosmetic compositions | |
KR100451473B1 (ko) | 점착성이 감소된 니아신아미드 조성물 | |
JP3786211B2 (ja) | スキンケア組成物および皮膚外観の改良方法 | |
MXPA01008896A (en) | Skin care compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020726 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20040901 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050111 |